LU82332A1 - Preparation des derives hydroxyles de l'isopropylamino-pyrimidine - Google Patents

Preparation des derives hydroxyles de l'isopropylamino-pyrimidine Download PDF

Info

Publication number
LU82332A1
LU82332A1 LU82332A LU82332A LU82332A1 LU 82332 A1 LU82332 A1 LU 82332A1 LU 82332 A LU82332 A LU 82332A LU 82332 A LU82332 A LU 82332A LU 82332 A1 LU82332 A1 LU 82332A1
Authority
LU
Luxembourg
Prior art keywords
isopropylamino
pyrimidine
preparation
hydrogen atom
hydroxyl derivatives
Prior art date
Application number
LU82332A
Other languages
English (en)
French (fr)
Inventor
A Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of LU82332A1 publication Critical patent/LU82332A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
LU82332A 1979-04-30 1980-04-03 Preparation des derives hydroxyles de l'isopropylamino-pyrimidine LU82332A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
LU82332A1 true LU82332A1 (fr) 1980-07-02

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
LU82333A LU82333A1 (fr) 1979-04-30 1980-04-03 Preparation des derives hydroxyles de l'isopropyl-amino-pyrimidine
LU82332A LU82332A1 (fr) 1979-04-30 1980-04-03 Preparation des derives hydroxyles de l'isopropylamino-pyrimidine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU82333A LU82333A1 (fr) 1979-04-30 1980-04-03 Preparation des derives hydroxyles de l'isopropyl-amino-pyrimidine

Country Status (26)

Country Link
JP (2) JPS55145671A (cs)
AR (2) AR222870A1 (cs)
AT (2) AT380012B (cs)
BE (2) BE882593A (cs)
CH (2) CH645633A5 (cs)
DK (2) DK183780A (cs)
EG (2) EG14259A (cs)
ES (2) ES8103060A1 (cs)
FI (2) FI66359C (cs)
FR (2) FR2455588A1 (cs)
GB (2) GB2055801B (cs)
HK (2) HK55583A (cs)
IE (2) IE49591B1 (cs)
IN (2) IN154066B (cs)
IT (2) IT1141296B (cs)
LU (2) LU82333A1 (cs)
MA (1) MA18824A1 (cs)
MX (2) MX5878E (cs)
MY (2) MY8400203A (cs)
NL (2) NL8002272A (cs)
NO (2) NO154056C (cs)
NZ (2) NZ193421A (cs)
OA (2) OA06525A (cs)
PT (2) PT71154A (cs)
SG (2) SG22283G (cs)
ZA (2) ZA801960B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (cs) * 1987-03-13 1988-09-26
JPS645795U (cs) * 1987-06-26 1989-01-13
JPH01100695U (cs) * 1987-12-21 1989-07-06
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Also Published As

Publication number Publication date
OA06527A (fr) 1981-07-31
JPS6116272B2 (cs) 1986-04-28
MX6514E (es) 1985-06-26
ATA221580A (de) 1985-08-15
SG22583G (en) 1983-12-16
FI66358C (fi) 1984-10-10
LU82333A1 (fr) 1980-07-02
NZ193421A (en) 1981-11-19
GB2055801A (en) 1981-03-11
IE49591B1 (en) 1985-10-30
SG22283G (en) 1983-12-16
BE882594A (fr) 1980-07-31
AR222869A1 (es) 1981-06-30
JPS6116273B2 (cs) 1986-04-28
PT71155A (en) 1980-05-01
GB2054556A (en) 1981-02-18
DK183880A (da) 1980-10-31
IT8021542A0 (it) 1980-04-22
AR222870A1 (es) 1981-06-30
AT380012B (de) 1986-03-25
IT1141296B (it) 1986-10-01
ES490999A0 (es) 1981-02-16
IT1141487B (it) 1986-10-01
FR2455588B1 (cs) 1983-04-15
FI801084A (fi) 1980-10-31
ZA801960B (en) 1981-04-29
FI66359C (fi) 1984-10-10
CH645633A5 (en) 1984-10-15
NO154055C (no) 1986-07-09
NZ193422A (en) 1981-12-15
JPS55145671A (en) 1980-11-13
IE800864L (en) 1980-10-30
JPS55145670A (en) 1980-11-13
FR2455589B1 (cs) 1981-07-10
NO154055B (no) 1986-04-01
NO801234L (no) 1980-10-31
FI66359B (fi) 1984-06-29
PT71154A (en) 1980-05-01
MA18824A1 (fr) 1980-12-31
ES8103060A1 (es) 1981-02-16
FI66358B (fi) 1984-06-29
AT380013B (de) 1986-03-25
HK55583A (en) 1983-11-25
HK55683A (en) 1983-11-25
IE49709B1 (en) 1985-11-27
MY8400204A (en) 1984-12-31
NL8002272A (nl) 1980-11-03
CH645361A5 (en) 1984-09-28
NO154056B (no) 1986-04-01
NO801235L (no) 1980-10-31
FR2455589A1 (fr) 1980-11-28
BE882593A (fr) 1980-07-31
GB2055801B (en) 1983-02-09
FI801083A (fi) 1980-10-31
IN154066B (cs) 1984-09-15
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
ES8103061A1 (es) 1981-02-16
IN154067B (cs) 1984-09-15
EG14284A (en) 1983-09-30
ZA801958B (en) 1981-04-29
FR2455588A1 (fr) 1980-11-28
NL8002271A (nl) 1980-11-03
NO154056C (no) 1986-07-09
ES491000A0 (es) 1981-02-16
IT8021543A0 (it) 1980-04-22
MY8400203A (en) 1984-12-31
OA06525A (fr) 1981-07-31
ATA221680A (de) 1985-08-15
GB2054556B (en) 1983-01-26
DK183780A (da) 1980-10-31
MX5878E (es) 1984-08-16

Similar Documents

Publication Publication Date Title
DE69209969T2 (de) Wasserlösliche Camptothecinderivate
EP0284621A1 (en) PSYCHOSTIMULATING AGENT.
DE3346573A1 (de) 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
CH644368A5 (en) Hydroxylated pyrimidine derivatives, their preparation and therapeutic composition containing them
DE2722162A1 (de) Verfahren zur herstellung von phosphonigen saeuren
DD150457A5 (de) Verfahren zur herstellung der(r,r)optisch isomeren verbindungen von labetalol
LU82332A1 (fr) Preparation des derives hydroxyles de l'isopropylamino-pyrimidine
EP0002672B1 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH651294A5 (fr) Acides amino-2-halogenobenzoyl-3-methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques.
CA1132562A (en) Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use
US4524152A (en) 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
CA2346506C (fr) Derives d'aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone comme agonistes du recepteur 5-ht1
DE2114230C2 (de) Verfahren zur Herstellung von 8-Methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino(3,2,1-j,k)carbazolhydrochlorid
EP0737187B1 (fr) Derives de la benzoxazine, leurs procedes d'obtention et leur utilisation en tant que medicaments
US3590039A (en) N - (alpha,alpha,alpha,alpha',alpha',alpha' -hexafluoro - 3,5 - xylyl) anthranilic acid and salts thereof
HU201082B (en) Enolethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide, a process for their preparation and their use.
FR2518537A1 (fr) Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant
DE2004301A1 (de) Phenylserinderivate
DE1518334C3 (de) Substituierte Benzylamme und ihre Salze sowie Verfahren zu ihrer Herstellung
EP0003286A2 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0024616B1 (de) 1-(3'-Acyloxyphenyl)-2-aminoethanole, deren Säureadditionssalze, diese enthaltende Arzneimittel, sowie Verfahren zu ihrer Herstellung
FR2527605A1 (fr) Derives de piperazine, procede de fabrication et medicaments en resultant
US4332807A (en) N-Substituted-benzyl-11-endo-amino-5,6,7,8,9,10-hexahydro-2-hydroxy (or methoxy)-6,9-methanobenzocyclooctene (or nonene) centrally-acting analgesics
EP0246946A2 (fr) Nouvelles compostions pharmaceutiques à action anti-progestéronique et leur procédé d'obtention
LU85312A1 (fr) Diphenylazomethines substituees,leur preparation et leur application en therapeutique